Genpharmasec Limited (BOM:531592)
India · Delayed Price · Currency is INR 1.070
-0.050 (-4.46%)
At close: Oct 1, 2026
Genpharmasec Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 592 | 432 | 1,009 | 1,235 | 861 | 1,523 | |
Market Cap Growth | -43.68% | -57.18% | -18.31% | 43.41% | -43.45% | -31.34% |
Enterprise Value | 835 | 491 | 1,021 | 1,221 | 805 | 1,447 |
Last Close Price | 1.07 | 0.78 | 1.89 | 2.23 | 1.87 | 3.30 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 91.45 | 26.93 | 63.60 | - | 76.55 | - |
PS Ratio | 0.33 | 0.31 | 2.99 | 4.06 | 3.38 | 5.57 |
PB Ratio | 0.90 | 0.66 | 1.55 | 1.91 | 5.62 | 9.91 |
P/TBV Ratio | 1.23 | 0.90 | 1.55 | 1.92 | 5.62 | 9.91 |
P/OCF Ratio | - | - | 34.18 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.47 | 0.35 | 3.03 | 4.01 | 3.15 | 5.30 |
EV/EBITDA Ratio | 64.83 | 64.67 | 627.67 | 5926.15 | 300.20 | - |
EV/EBIT Ratio | - | - | - | 31302.23 | 324.00 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.53 | 0.53 | 0.08 | 0.06 | 0.20 | - |
Debt / EBITDA Ratio | 27.13 | 25.53 | 8.40 | 84.54 | 11.50 | - |
Net Debt / Equity Ratio | 0.38 | 0.38 | 0 | -0.28 | -0.04 | -0.39 |
Net Debt / EBITDA Ratio | 19.31 | 32.78 | 0.08 | -868.31 | -2.14 | 11.40 |
Net Debt / FCF Ratio | - | -1.38 | 0.00 | 6.04 | 0.19 | 2.45 |
Asset Turnover | - | 1.28 | 0.45 | 0.67 | 1.23 | 1.11 |
Inventory Turnover | - | 12.14 | 4.13 | 2.93 | 2.75 | 4.22 |
Quick Ratio | - | 0.86 | 1.92 | 11.58 | 4.54 | 2.02 |
Current Ratio | - | 1.71 | 2.69 | 15.16 | 9.17 | 3.43 |
Return on Equity (ROE) | - | 0.86% | 2.41% | -0.42% | 7.33% | -1.16% |
Return on Assets (ROA) | - | -0.46% | -0.15% | 0.01% | 0.75% | -1.35% |
Return on Invested Capital (ROIC) | -1.48% | -0.59% | -0.23% | -0.01% | 2.05% | -6.79% |
Return on Capital Employed (ROCE) | - | -0.90% | -0.30% | 0.00% | 1.40% | -3.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.09% | 3.71% | 1.57% | -0.14% | 1.31% | -0.14% |
FCF Yield | -30.50% | -41.84% | -2.73% | -2.40% | -3.57% | -1.59% |
Buyback Yield / Dilution | - | - | -80.25% | -10.96% | - | -2.06% |